Navigation Links
2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
Date:6/3/2009

LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008. The remarkable success of last year's meeting generated the positive buzz responsible for much of the growth. Attendance for the September 14-16, 2009 event is expected to be about 1000.

Also attracting high attendance is the conference program newly focused on the outsourcing needs of small molecule biotech companies, today's drivers behind much of the growth of the pharmaceutical industry, reports Mark Alexay of Apaporis LLC, the organizer. In 2009, 35 different biotech company chemists are participating as speakers.

The high interest in the new biotech track offers biotech company process and medicinal chemistry, supply chain and manufacturing management personnel opportunity to share their chemical sourcing experiences and strategies. Given the small size of most of the firms, the 35 speakers provide a rare glimpse into the challenges they face to secure external suppliers to do their scale up manufacturing. The track may be viewed at http://www.chemoutsourcing.com/agenda.trackd.php

Biotech participants include speakers from King Pharmaceuticals, Medivation, GPC Biotech, Theravance, Bionumerik Pharmaceuticals, Anthera Pharmaceuticals, Palatin Technologies, Magen Biosciences, Inspire Pharmaceuticals, Geron Pharmaceuticals, Phenomix Corporation and CoNCERT Pharmaceuticals.

The show will take place at the beachfront Ocean Place Resort in Long Branch, NJ. The high end venue affords beach area for nightly barbecues and parties to facilitate informal networking. The show kicks off on Sunday, September 13 and ends Wednesday, September 16.

Additional speakers include BioMarin Pharmaceuticals, Array BioPharma, Reata Pharmaceuticals, Proteolix, Novalar Pharmaceuticals, Lexicon Pharmaceuticals, Orexigen Therapeutics, Targacept, Helsinn Therapeutics, OSI Prosidion, NovaDel Pharma, Anacor Pharmaceuticals, Ceragenix, Millennium Pharmaceuticals (Takeda), Pharmasset, Oscient Pharmaceuticals, Cenomed Biosciences, Alkermes, Epix Pharmaceuticals, and Ardea Biosciences.

The exhibit area is strictly limited to 100 booths and is nearly full 3 1/2 months before the show. The list and exhibitor profiles may be viewed at http://www.chemoutsourcing.com/sponsors.php

For more information about Pharma ChemOutsourcing and to view the 120-speaker conference or attendee list at www.chemoutsourcing.com or contact Mark Alexay at malexay@chemoutsourcing.com or 201.452.4023.

Pharma ChemOutsourcing is organized by Apaporis LLC.


'/>"/>
SOURCE Apaporis LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):